arrow
X

Xu‐Chao Zhang

Johns Hopkins Medicine
H指数:49
被引数:9,024
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

FUS inactivation promotes leptomeningeal metastasis of lung cancer through the up-regulation of CD36

FUS失活通过上调CD36促进肺癌的脑膜转移

2026-08-260
PRE
Fenestrating Adenocarcinoma A Novel Salivary Gland Cancer With EWSR1::BEND2 Fusion and Predilection for the Pharynx

筛状腺癌:一种具有EWSR1::BEND2融合基因且好发于咽部的唾液腺癌新类型

2026-01-011
PRE
Single-cell RNA profiling reveals an immunosuppressive microenvironment in EGFR double-mutant non-small cell lung cancer

单细胞RNA分析揭示了EGFR双突变非小细胞肺癌的免疫抑制微环境

2025-10-310
PRE
High specific capacity O3-NaNi₁/₃Fe₁/₃Mn₁/₃O₂ cathode material for sodium-ion batteries

高比容量O3-NaNi₁/₃Fe₁/₃Mn₁/₃O₂正极材料用于钠离子电池

2025-07-040
PRE
Distinct Role of TP53 Co-mutations in Different EGFR Subtypes Mediating the Response to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

TP53共突变在不同EGFR亚型中调节非小细胞肺癌对EGFR酪氨酸激酶抑制剂反应的特异作用

2025-04-230
PREAI
Spatial proximity of CD8+ T cells to tumor cells predicts neoadjuvant therapy efficacy in breast cancer
2025-02-100
OAAI
The role of institutional quality in the nexus between green financing and sustainable development

制度质量在绿色融资与可持续发展关系中的作用

2025-01-0110
PRE
The malic acid inhibiting inflammation in ankylosing spondylitis by interfering M1 macrophage polarization
2025-01-010
OAAI
PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-Rearranged NSCLC and Central Nervous System Disease

PEARL:一项关于洛拉替尼在ALK重排非小细胞肺癌合并中枢神经系统疾病患者中的多中心II期研究

2024-12-040
PRE
Malignant Salivary Gland Neoplasm of the Tongue Base with EWSR1::BEND2 Fusion: An Unusual Case with Literature Review
2024-11-041
PRE
Hovering efficiency optimization of ducted propeller with large blade tip clearance based on grooved duct configuration
2024-07-0128
PRE
Redoxhigh phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma

KEAP1/STK11/SMARCA4/NRF2突变介导的Redoxhigh表型减少了组织驻留的记忆性CD8 T细胞并减弱了肺腺癌的免疫治疗效果

2024-04-092
OA
Plasma ddPCR for the detection of MET amplification in advanced NSCLC patients: a comparative real-world study
2024-02-071
OAAI
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial

未经治疗的晚期非小细胞肺癌患者sintilimab与pembrolizumab联合或不联合铂类双重化疗的PD-L1表达指南 (CTONG1901): 一项2期随机对照试验

2024-02-016
OAAI
Protective role of curcumin in Singapore grouper iridovirus-induced liver injury in orange-spotted grouper (Epinephelus coioides)
2023-12-012
PRE
Understanding the efficiency and evolution of China's Green Economy: A province-level analysis
2023-09-282
PRE
Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

东亚地区肺腺癌的全基因组关联研究及与欧洲人群的比较

2023-05-2623
OAAI
Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapy
2023-04-291
OA
Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients
2023-04-224
OAAI
Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancer

驱动阳性非小细胞肺癌骨转移免疫微环境的异质性

2023-04-173
PRE